AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $95.9, along with a high estimate of $150.00 and a low estimate of $64.00. Experiencing a 1 ...

Celcuity Inc. (Nasdaq: CELC) (the 'Company”), a clinical-stage biotechnology company pursuing development of targeted ...

Investment firm Carlyle announced on Monday it has rejigged its senior leadership ranks and named three of its veterans for ...

CNW/ - As Canada looks to encourage greater economic growth amid shifting economic and geopolitical forces, new research from TD reveals that many ...

Stryker Corporation (NYSE: SYK) is one of the top low volatility healthcare stocks to buy now. In a report released on July ...

VantageScore could potentially help younger borrowers or others with limited credit histories qualify for home loans or get ...

AtkinsRéalis’s push into the US nuclear reactor market follows publication of four executive orders by the Trump ...

After finally getting approval from the Federal Communications Commission, Skydance Media is just weeks away from completing ...

Airbnb built a travel empire by leveraging something the industry had long overlooked: people’s homes. Its early success came ...

NEW YORK] Intel shares sank 8 per cent on Friday (Jul 25) after the company warned of exiting chip manufacturing if it fails ...